2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2023 | 0 | 11.996.753 | 0 | 1 | ||
2021 | 0 | 5.999.999 | 55.450 | 1 | ||
2020 | 0 | 11.996.481 | 84.940 | 2 | ||
2019 | 0 | 15.000.000 | 56.200 | 1 |
Total number of partners: 93
Partner loyalty:
Frequent Partner: (> 2 projects): 19
Rare Partner: 74
Frequent / Rare Partner Ratio: 0.26
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2023-01-01 | Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma | GENIAL | participant | 11.996.753 | 14 |
2021-03-01 | NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242 | A-TANGO | participant | 5.999.999 | 14 |
2020-04-01 | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | DECISION | participant | 6.000.000 | 25 |
2020-01-01 | Screening for liver fibrosis - population-based study across European countries | LiverScreen | participant | 5.996.481 | 23 |
2019-01-01 | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | MICROB-PREDICT | participant | 15.000.000 | 22 |